Argenx SE - Company Profile
Powered by 
All the data and insights you need on Argenx SE in one report.
$295
- Save hours of research time and resources with
our up-to-date Argenx SE Strategy Report
- Understand Argenx SE position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Argenx SE’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 06 Jun 2022 | Medison Pharma Enters into Agreement with argenx | Partnership | - |
Medison Pharma Ltd
Argenx SE |
| 22 Mar 2022 | Argenx Completes Full Exercise of Underwriters Over-Allotment Option of Public Offering of American Depository Shares for USD805 Million | Equity Offering | - |
Argenx SE |
| 20 Jan 2022 | Genpharm Services Enters into Agreement with argenx | Partnership | - |
Argenx SE
Genpharm Services
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward